Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection Fraction.
Kamoshida J, Ueda N, Ishibashi K, Noda T, Kawabata T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Kusano K. Kamoshida J, et al. Among authors: wakamiya a. Circ Rep. 2024 Sep 14;6(10):407-414. doi: 10.1253/circrep.CR-24-0065. eCollection 2024 Oct 10. Circ Rep. 2024. PMID: 39391552 Free PMC article.
Significance of effective cardiac resynchronization therapy pacing for clinical responses: An analysis based on the effective cardiac resynchronization therapy algorithm.
Oka S, Ueda N, Ishibashi K, Noda T, Miyazaki Y, Wakamiya A, Shimamoto K, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Kusano K. Oka S, et al. Among authors: wakamiya a. Heart Rhythm. 2023 Sep;20(9):1289-1296. doi: 10.1016/j.hrthm.2023.06.005. Epub 2023 Jun 10. Heart Rhythm. 2023. PMID: 37307884
Implications of ventricular arrhythmia after cardiac resynchronization therapy.
Ueda N, Ishibashi K, Noda T, Oka S, Miyazaki Y, Shimamoto K, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Kusano K. Ueda N, et al. Among authors: wakamiya a. Heart Rhythm. 2024 Feb;21(2):163-171. doi: 10.1016/j.hrthm.2023.09.014. Epub 2023 Sep 20. Heart Rhythm. 2024. PMID: 37739199
N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients.
Ueda N, Kataoka N, Miyazaki Y, Shimamoto K, Wakamiya A, Nakajima K, Kamakura T, Wada M, Ishibashi K, Yamagata K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kinugawa K, Minamino N, Kusano K. Ueda N, et al. Among authors: wakamiya a. Int J Cardiol Heart Vasc. 2023 Oct 24;49:101282. doi: 10.1016/j.ijcha.2023.101282. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 37908624 Free PMC article.
Clinical Significance of Atrial Tachyarrhythmia Duration for Ventricular Arrhythmia in Patients With Cardiac Resynchronization Therapy.
Ueda N, Noda T, Kanaoka K, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Yamagata K, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Yasuda S, Kusano K. Ueda N, et al. Among authors: wakamiya a. Circ J. 2024 Jun 25;88(7):1138-1146. doi: 10.1253/circj.CJ-23-0547. Epub 2023 Dec 5. Circ J. 2024. PMID: 38057103 Free article. Clinical Trial.
Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline　- A Multicenter Validation Study.
Wakamiya A, Kamakura T, Shinohara T, Yodogawa K, Murakoshi N, Morita H, Takahashi N, Inden Y, Shimizu W, Nogami A, Horie M, Nakajima K, Kataoka N, Wada M, Yamagata K, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Noda T, Aiba T, Yasuda S, Ieda M, Kusano K. Wakamiya A, et al. Circ J. 2020 Nov 25;84(12):2158-2165. doi: 10.1253/circj.CJ-19-0910. Epub 2020 Oct 17. Circ J. 2020. PMID: 33071242 Free article.
Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome.
Aiba T, Ishibashi K, Hattori K, Wada M, Ueda N, Miyazaki Y, Wakamiya A, Yamagata K, Inoue Y, Miyamoto K, Nagase S, Kusano K. Aiba T, et al. Among authors: wakamiya a. Circ J. 2021 Oct 25;85(11):2117. doi: 10.1253/circj.CJ-21-0515. Epub 2021 Jul 17. Circ J. 2021. PMID: 34275963 Free article. No abstract available.
169 results